ML | pharmaphorum

R&D

As the drug development landscape becomes more complex, pharmaceutical and biotech companies understand their business strategies have to evolve.

News

Novo Nordisk has been sent a warning letter from the FDA for violations of postmarketing adverse drug experience (PADE) regulations.

Sales & Marketing

As AI continues to reshape the healthcare landscape, pharma teams are beginning to leverage synthetic personas.

ML